JP

Yamamoto Yuji

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yamamoto Yuji. Retrieved from https://idiyas.com/inventor/yamamoto-yuji

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Yamamoto Yuji: Innovator in Pharmaceutical Chemistry

Introduction

Yamamoto Yuji is a notable inventor in the field of pharmaceutical chemistry, based in Japan. He has contributed to the development of complex compounds that hold potential therapeutic applications. His work reflects a commitment to advancing medical science through innovative chemical solutions.

Latest Patents

Yamamoto Yuji's most recent patent is titled "(6s,9as)-N-Benzyl-8-((6-(3-(4-Ethylpiperazin-1-Yl)azetidin-1-Yl)pyridin-2-Yl)methyl)-6-((2-Fluoro-4-Hydroxyphenyl)methyl)-4,7-Dioxo-2-(prop-2-En-1-Yl)-Octahydro-1h-Pyrazino[2,1-C][1,2,4]triazine-1-Carboxamide And Pharmaceutically Acceptable Salts Thereof." This compound is represented by a general formula that includes various alkyl groups and halogen atoms, showcasing his expertise in synthesizing complex molecular structures.

Career Highlights

Throughout his career, Yamamoto has worked with prominent companies in the pharmaceutical industry, including Eisai R&D Management Co., Ltd. and Prism Pharma Co., Ltd. His experience in these organizations has allowed him to collaborate on significant research projects and contribute to the development of new medications.

Collaborations

Yamamoto has collaborated with esteemed colleagues such as Inoue Satoshi and Iso Kentaro. These partnerships have fostered a productive environment for innovation and have led to advancements in their respective fields.

Conclusion

Yamamoto Yuji is a dedicated inventor whose work in pharmaceutical chemistry has the potential to impact medical treatments significantly. His innovative compounds and collaborations highlight his contributions to the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…